BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-11.11%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
-$1.54B
(-18%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
34.72%
Holding
187
New
10
Increased
57
Reduced
82
Closed
15
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$58.1M |
| 2 |
Pfizer
PFE
|
$41.4M |
| 3 |
Harmony Biosciences
HRMY
|
$28.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$25.4M |
| 5 |
Celldex Therapeutics
CLDX
|
$24.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$98M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$85.7M |
| 3 |
AbbVie
ABBV
|
$47.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$46.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 98.26% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Pfizer
PFE
$140B
| $43.8M | 0.62% |
835,684
+789,184
| +1,697% | +$41.4M |
|
52
Halozyme
HALO
$8.69B
| $42.7M | 0.6% |
971,300
-52,900
| -5% | -$2.33M |
|
|
ABMD
53
DELISTED
Abiomed Inc
ABMD
| $42M | 0.59% |
169,509
+19,331
| +13% | +$4.78M |
|
54
Idexx Laboratories
IDXX
$51.2B
| $40.6M | 0.57% |
115,773
-2,037
| -2% | -$714K |
|
55
Thermo Fisher Scientific
TMO
$183B
| $39M | 0.55% |
71,818
-815
| -1% | -$443K |
|
|
SILK
56
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $38.1M | 0.54% |
1,047,286
+1,719
| +0.2% | +$62.6K |
|
57
Globus Medical
GMED
$8.04B
| $36.9M | 0.52% |
656,681
-88,573
| -12% | -$4.97M |
|
58
IQVIA
IQV
$31B
| $36.6M | 0.52% |
168,598
+9,478
| +6% | +$2.06M |
|
59
Legend Biotech
LEGN
$6.41B
| $34.7M | 0.49% |
630,439
-29,630
| -4% | -$1.63M |
|
60
Outset Medical
OM
$233M
| $34.6M | 0.49% |
155,115
+20,638
| +15% | +$4.6M |
|
|
61
Harmony Biosciences
HRMY
$2.11B
| $34.2M | 0.48% |
702,068
+577,107
| +462% | +$28.1M |
|
62
Veeva Systems
VEEV
$43.9B
| $33.4M | 0.47% |
168,776
+8,175
| +5% | +$1.62M |
|
63
Align Technology
ALGN
$9.72B
| $32M | 0.45% |
135,240
-6,111
| -4% | -$1.45M |
|
64
Axsome Therapeutics
AXSM
$6.11B
| $31.3M | 0.44% |
817,141
+97,659
| +14% | +$3.74M |
|
65
Exact Sciences
EXAS
$9.76B
| $29.9M | 0.42% |
758,023
+38,720
| +5% | +$1.53M |
|
66
Baxter International
BAX
$12.1B
| $29.4M | 0.42% |
457,819
-32,061
| -7% | -$2.06M |
|
67
Adaptive Biotechnologies
ADPT
$1.92B
| $28.6M | 0.4% |
3,539,055
+393,762
| +13% | +$3.19M |
|
68
Zimmer Biomet
ZBH
$20.8B
| $28M | 0.4% |
266,087
-4,647
| -2% | -$488K |
|
69
Esperion Therapeutics
ESPR
$488M
| $26.9M | 0.38% |
4,235,264
-63,900
| -1% | -$406K |
|
|
HZNP
70
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $26.9M | 0.38% |
337,434
-7,666
| -2% | -$611K |
|
|
ACCD
71
DELISTED
Accolade, Inc. Common Stock
ACCD
| $26.9M | 0.38% |
3,634,886
+253,379
| +7% | +$1.87M |
|
72
Aurinia Pharmaceuticals
AUPH
$1.6B
| $26.8M | 0.38% |
2,671,413
+265,588
| +11% | +$2.67M |
|
73
Pacific Biosciences
PACB
$369M
| $26.3M | 0.37% |
5,961,229
+1,079,477
| +22% | +$4.77M |
|
74
AtriCure
ATRC
$1.77B
| $26.2M | 0.37% |
641,896
+43,291
| +7% | +$1.77M |
|
75
Cooper Companies
COO
$13.3B
| $25.5M | 0.36% |
325,916
-6,948
| -2% | -$544K |
|